Daratumumab

ATC L01FC01 · 9 markets · 39 records

Daratumumab 9 markets · 39 records Forms

AU 10 records · 7 strengths

100 mg/5 mLinjectionDARZALEX also in US·GB·SG
1,800 mg/15 mLinjectionDarzalex SC also in US·GB·SG
1,800 mginjectionDARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial also in ES·TW unknown
400 mg/20 mLinjectionDARZALEX also in GB·SG
400 mginjectionDARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial unknown
100 mginjectionDARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial unknown

Records without a stated strength · 1 DARZALEX、Darzalex SC

ES 7 records · 2 strengths

1,800 mginjectionDARZALEX also in AU·TW
20 mg/1 mLinjectionDARZALEX

US 3 records · 2 strengths

100 mg/5 mLinjectionDARZALEX+1Darzalex IV also in AU·GB·SG
1,800 mg/15 mLinjectionDarzalex Faspro also in AU·GB·SG

GB 3 records · 3 strengths

100 mg/5 mLinjectionDarzalex 100mg/5ml concentrate for solution for infusion vials also in AU·US·SG
1,800 mg/15 mLinjectionDarzalex 1800mg/15ml solution for injection vials also in AU·US·SG
400 mg/20 mLinjectionDarzalex 100mg/5ml concentrate for solution for infusion vials also in AU·SG

CA 3 records · 2 strengths

120 mg/1 mLliquidDarzalex SC
20 mg/1 mLliquidDARZALEX

SG 3 records · 3 strengths

100 mg/5 mLinjectionDARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML also in AU·US·GB
1,800 mg/15 mLinjectionDARZALEX SC SOLUTION FOR INJECTION 1800MG/15ML also in AU·US·GB
400 mg/20 mLinjectionDARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML also in AU·GB

HK 3 records · 1 strengths

Records without a stated strength · 1 Darzalex 1800mg solution for subcutaneous injection、DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML (SWITZERLAND)、DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML

TW 2 records · 2 strengths

1,800 mginjectionDarzalex 1800mg solution for subcutaneous+1兆科皮下注射劑1800毫克 also in AU·ES

Records without a stated strength · 1 Darzalex Concentrate for solution for infusion 20mg/ml、兆科注射劑20毫克/毫升

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 DARZALEX

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU
100 mg/5 mL injection	DARZALEX Darzalex IV	Darzalex 100mg/5ml concentrate for solution for infusion vials	not recorded	DARZALEX	DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML	not recorded	not recorded	not recorded	not recorded
1,800 mg/15 mLRecorded as: 1.8 g/15 mL injection	Darzalex Faspro	Darzalex 1800mg/15ml solution for injection vials	not recorded	Darzalex SC	DARZALEX SC SOLUTION FOR INJECTION 1800MG/15ML	not recorded	not recorded	not recorded	not recorded
1,800 mg injection	not recorded	not recorded	not recorded	DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial	not recorded	DARZALEX	Darzalex 1800mg solution for subcutaneous 兆科皮下注射劑1800毫克	not recorded	not recorded
400 mg/20 mL injection	not recorded	Darzalex 100mg/5ml concentrate for solution for infusion vials	not recorded	DARZALEX	DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML	not recorded	not recorded	not recorded	not recorded
120 mg/1 mL liquid	not recorded	not recorded	Darzalex SC	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
20 mg/1 mL liquid	not recorded	not recorded	DARZALEX	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
400 mg injection	not recorded	not recorded	not recorded	DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg injection	not recorded	not recorded	not recorded	DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial	not recorded	not recorded	not recorded	not recorded	not recorded
20 mg/1 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	DARZALEX	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	DARZALEX Darzalex SC	not recorded	not recorded	not recorded	Darzalex 1800mg solution for subcutaneous injection DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML (SWITZERLAND) DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML	DARZALEX
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Darzalex Concentrate for solution for infusion 20mg/ml 兆科注射劑20毫克/毫升	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in CA · ES and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · ES que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · ES 有记录（未在本表显示）。另有 3 個規格/劑型僅在 CA · ES 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.